This is Part Three of a three-part series. Part I. Part II)A Silicon Valley company with early funding from the US Department of Defense’s highly secretive Defense Advanced Research Projects Agency (DARPA,) is expecting approval of an injectable, permanent under-the-skin biochip sensor made of advanced hydrogel material sometime in the spring.The chip is being touted as a way to detect COVID infections as soon as the body begins to show symptoms.It has been known since the end of May, according to the CDC, that COVID is a 99.8% survival rate virus, similar to flu, which is 99.9%. While it is...